- Home
- EVH
as 07-26-2024 4:00pm EST
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
| Founded: | 2011 | Country: | United States |
| Employees: | N/A | City: | ARLINGTON |
| Market Cap: | 2.4B | IPO Year: | 2015 |
| Target Price: | $41.75 | AVG Volume (30 days): | 2.7M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 8 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.26 | EPS Growth: | N/A |
| 52 Week Low/High: | $17.98 - $35.00 | Next Earning Date: | 08-08-2024 |
| Revenue: | $2,175,859,000 | Revenue Growth: | 46.76% |
| Revenue Growth (this year): | 32.49% | Revenue Growth (next year): | 14.99% |
Stock Insider Trading Activity of Evolent Health Inc (EVH)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Blackley Seth | EVH | Chief Executive Officer | Dec 4 '23 | Sell | $25.74 | 27,484 | $707,438.16 | 751,161 | SEC Form 4 |
| Blackley Seth | EVH | Chief Executive Officer | Dec 4 '23 | Sell | $26.61 | 92,616 | $2,464,511.76 | 658,545 | SEC Form 4 |
| Blackley Seth | EVH | Chief Executive Officer | Dec 4 '23 | Sell | $27.25 | 20,900 | $569,525.00 | 637,645 | SEC Form 4 |
Latest Evolent Health Inc News
EVH Breaking Stock News: Dive into EVH Ticker-Specific Updates for Smart Investing
MT Newswires
3 days ago
Evolent Health's EBITDA Growth Poised to Accelerate in H2 Despite Headwinds in Q2, RBC Says
Zacks
10 days ago
Evolent Health (EVH) Moves 12.8% Higher: Will This Strength Last?
Simply Wall St.
14 days ago
Investors Will Want Evolent Health's (NYSE:EVH) Growth In ROCE To Persist
PR Newswire
16 days ago
Evolent To Release Second Quarter 2024 Financial Results on Thursday, August 8, 2024
CNW Group
2 months ago
Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku
CNW Group
2 months ago
HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA
PR Newswire
2 months ago
IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse
Business Wire
2 months ago
Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store
Compare EVH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "EVH Evolent Health Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.